Ulusan, S. Et Al. 2023. Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity. Anatolian Journal of Cardiology , vol.27, no.6 , 339-347.

Ulusan, S., GÜLLE, K., PEYNİRCİ, A., SEVİMLİ, M., KARAİBRAHİMOĞLU, A., & KUYUMCU, M. S., (2023). Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity. Anatolian Journal of Cardiology , vol.27, no.6, 339-347.

Ulusan, Sebahat Et Al. "Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity," Anatolian Journal of Cardiology , vol.27, no.6, 339-347, 2023

Ulusan, Sebahat Et Al. "Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity." Anatolian Journal of Cardiology , vol.27, no.6, pp.339-347, 2023

Ulusan, S. Et Al. (2023) . "Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity." Anatolian Journal of Cardiology , vol.27, no.6, pp.339-347.

@article{article, author={Sebahat Ulusan Et Al. }, title={Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity}, journal={Anatolian Journal of Cardiology}, year=2023, pages={339-347} }